< 0 1 0 1 O
18 2 4 2 4 B-upper_bound
years 5 10 5 10 I-upper_bound
of 11 13 11 13 O
age 14 17 14 17 B-age
or 18 20 18 20 O
> 21 22 21 22 O
80 22 24 22 24 B-lower_bound
years 25 30 25 30 I-lower_bound
of 31 33 31 33 O
age 34 37 34 37 O

Abnormal 0 8 38 46 B-clinical_variable
liver 9 14 47 52 I-clinical_variable
tests 15 20 53 58 I-clinical_variable
alanine 21 28 59 66 I-clinical_variable
aminotransferase 29 45 67 83 I-clinical_variable
( 46 47 84 85 I-clinical_variable
ALT 47 50 85 88 I-clinical_variable
) 50 51 88 89 I-clinical_variable

Active 0 6 90 96 B-chronic_disease
tuberculosis 7 19 97 109 I-chronic_disease
or 20 22 110 112 O
hepatitis 23 32 113 122 B-chronic_disease
B 33 34 123 124 I-chronic_disease
infection 35 44 125 134 I-chronic_disease

Any 0 3 135 138 O
cancer 4 10 139 145 B-cancer
within 11 17 146 152 O
the 18 21 153 156 O
past 22 26 157 161 B-upper_bound
5 27 28 162 163 I-upper_bound
years 29 34 164 169 I-upper_bound

Any 0 3 170 173 O
identified 4 14 174 184 O
congenital 15 25 185 195 B-chronic_disease
or 26 28 196 198 O
acquired 29 37 199 207 B-chronic_disease
immunodeficiency 38 54 208 224 I-chronic_disease
( 55 56 225 226 O
e.g. 56 60 226 230 O
, 60 61 230 231 O
common 62 68 232 238 B-chronic_disease
variable 69 77 239 247 I-chronic_disease
immunodeficiency 78 94 248 264 I-chronic_disease
, 94 95 264 265 O
human 96 101 266 271 B-chronic_disease
immunodeficiency 102 118 272 288 I-chronic_disease
virus 119 124 289 294 I-chronic_disease
[ 125 126 295 296 I-chronic_disease
HIV 126 129 296 299 I-chronic_disease
] 129 130 299 300 I-chronic_disease
infection 131 140 301 310 I-chronic_disease
, 140 141 310 311 O
organ 142 147 312 317 B-treatment
transplantation 148 163 318 333 I-treatment
) 163 164 333 334 O

Any 0 3 335 338 O
live 4 8 339 343 B-treatment
vaccinations 9 21 344 356 I-treatment
within 22 28 357 363 O
30 29 31 364 366 B-upper_bound
days 32 36 367 371 I-upper_bound
prior 37 42 372 377 I-upper_bound
to 43 45 378 380 O
study 46 51 381 386 O
drug 52 56 387 391 O
administration 57 71 392 406 O
except 72 78 407 413 O
for 79 82 414 417 O
the 83 86 418 421 O
influenza 87 96 422 431 B-treatment
vaccine 97 104 432 439 I-treatment

Any 0 3 440 443 O
unstable 4 12 444 452 B-chronic_disease
or 13 15 453 455 I-chronic_disease
uncontrolled 16 28 456 468 I-chronic_disease
cardiovascular 29 43 469 483 I-chronic_disease
, 43 44 483 484 O
pulmonary 45 54 485 494 B-chronic_disease
, 54 55 494 495 O
hepatic 56 63 496 503 B-chronic_disease
, 63 64 503 504 O
renal 65 70 505 510 B-chronic_disease
, 70 71 510 511 O
endocrine 72 81 512 521 B-chronic_disease
/ 81 82 521 522 I-chronic_disease
metabolic 82 91 522 531 I-chronic_disease
, 91 92 531 532 O
or 93 95 533 535 O
other 96 101 536 541 O
medical 102 109 542 549 B-chronic_disease
disorder 110 118 550 558 I-chronic_disease
that 119 123 559 563 O
, 123 124 563 564 O
in 125 127 565 567 O
the 128 131 568 571 O
opinion 132 139 572 579 O
of 140 142 580 582 O
the 143 146 583 586 O
investigator 147 159 587 599 O
, 159 160 599 600 O
would 161 166 601 606 O
confound 167 175 607 615 O
the 176 179 616 619 O
study 180 185 620 625 O
results 186 193 626 633 O
or 194 196 634 636 O
compromise 197 207 637 647 O
patient 208 215 648 655 O
safety 216 222 656 662 O

Clinically 0 10 663 673 O
significant 11 22 674 685 O
extra 23 28 686 691 B-chronic_disease
- 28 29 691 692 I-chronic_disease
intestinal 29 39 692 702 I-chronic_disease
infection 40 49 703 712 I-chronic_disease
( 50 51 713 714 O
e.g. 51 55 714 718 O
, 55 56 718 719 O
pneumonia 57 66 720 729 B-chronic_disease
, 66 67 729 730 O
pyelonephritis 68 82 731 745 B-chronic_disease
) 82 83 745 746 O
within 84 90 747 753 O
30 91 93 754 756 B-upper_bound
days 94 98 757 761 I-upper_bound
of 99 101 762 764 O
the 102 105 765 768 O
initial 106 113 769 776 O
screening 114 123 777 786 O
visit 124 129 787 792 O

Congestive 0 10 793 803 B-chronic_disease
heart 11 16 804 809 I-chronic_disease
failure 17 24 810 817 I-chronic_disease

Crohn 0 5 818 823 B-chronic_disease
's 5 7 823 825 I-chronic_disease
patients 8 16 826 834 O
have 17 21 835 839 O
a 22 23 840 841 O
Harvey 24 30 842 848 B-clinical_variable
Bradshaw 31 39 849 857 I-clinical_variable
index 40 45 858 863 I-clinical_variable
> 46 47 864 865 O
5 47 48 865 866 B-lower_bound

Evidence 0 8 867 875 O
of 9 11 876 878 O
or 12 14 879 881 O
treatment 15 24 882 891 O
for 25 28 892 895 O
C. 29 31 896 898 B-chronic_disease
difficile 32 41 899 908 I-chronic_disease
infection 42 51 909 918 I-chronic_disease
within 52 58 919 925 O
60 59 61 926 928 B-upper_bound
days 62 66 929 933 I-upper_bound
or 67 69 934 936 O
other 70 75 937 942 O
intestinal 76 86 943 953 O
pathogen 87 95 954 962 O
within 96 102 963 969 O
30 103 105 970 972 B-upper_bound
days 106 110 973 977 I-upper_bound
prior 111 116 978 983 O
to 117 119 984 986 O
enrollment 120 130 987 997 O

Oral 0 4 998 1002 B-treatment
corticosteroid 5 19 1003 1017 I-treatment
therapy 20 27 1018 1025 I-treatment

Patients 0 8 1026 1034 O
with 9 13 1035 1039 O
inflammatory 14 26 1040 1052 B-chronic_disease
bowel 27 32 1053 1058 I-chronic_disease
disease 33 40 1059 1066 I-chronic_disease
who 41 44 1067 1070 O
on 45 47 1071 1073 O
are 48 51 1074 1077 O
stable 52 58 1078 1084 O
doses 59 64 1085 1090 O
of 65 67 1091 1093 O
infliximab 68 78 1094 1104 B-treatment
or 79 81 1105 1107 O
adalimumab 82 92 1108 1118 B-treatment
for 93 96 1119 1122 O
at 97 99 1123 1125 O
least 100 105 1126 1131 O
3 106 107 1132 1133 B-lower_bound
months 108 114 1134 1140 I-lower_bound
who 115 118 1141 1144 O
experience 119 129 1145 1155 O
a 130 131 1156 1157 O
secondary 132 141 1158 1167 O
loss 142 146 1168 1172 O
of 147 149 1173 1175 O
response 150 158 1176 1184 O
to 159 161 1185 1187 O
the 162 165 1188 1191 O
medication 166 176 1192 1202 B-treatment
based 177 182 1203 1208 O
on 183 185 1209 1211 O
clinical 186 194 1212 1220 O
symptoms 195 203 1221 1229 O

Pregnant 0 8 1230 1238 B-pregnancy

Presence 0 8 1239 1247 O
of 9 11 1248 1250 O
at 12 14 1251 1253 O
least 15 20 1254 1259 O
one 21 24 1260 1263 B-lower_bound
objective 25 34 1264 1273 O
marker 35 41 1274 1280 O
of 42 44 1281 1283 O
active 45 51 1284 1290 O
disease 52 59 1291 1298 O
: 59 60 1298 1299 O
active 61 67 1300 1306 O
disease 68 75 1307 1314 O
based 76 81 1315 1320 O
on 82 84 1321 1323 O
endoscopy 85 94 1324 1333 O
, 94 95 1333 1334 O
elevated 96 104 1335 1343 O
fecal 105 110 1344 1349 O
calprotectin 111 123 1350 1362 O
or 124 126 1363 1365 O
serologic 127 136 1366 1375 O
markers 137 144 1376 1383 O
of 145 147 1384 1386 O
inflammation 148 160 1387 1399 O
( 161 162 1400 1401 O
C 162 163 1401 1402 O
- 163 164 1402 1403 O
reactive 164 172 1403 1411 O
protein 173 180 1412 1419 O
or 181 183 1420 1422 O
sedimentation 184 197 1423 1436 O
rate 198 202 1437 1441 O
) 202 203 1441 1442 O

Previous 0 8 1443 1451 O
noncompliant 9 21 1452 1464 O
with 22 26 1465 1469 O
medications 27 38 1470 1481 B-treatment

Receiving 0 9 1482 1491 O
any 10 13 1492 1495 O
immunomodulator 14 29 1496 1511 B-treatment
therapy 30 37 1512 1519 I-treatment
within 38 44 1520 1526 O
the 45 48 1527 1530 O
past 49 53 1531 1535 B-upper_bound
3 54 55 1536 1537 I-upper_bound
months 56 62 1538 1544 I-upper_bound

Ulcerative 0 10 1545 1555 B-chronic_disease
colitis 11 18 1556 1563 I-chronic_disease
patients 19 27 1564 1572 O
have 28 32 1573 1577 O
a 33 34 1578 1579 O
Ulcerative 35 45 1580 1590 B-clinical_variable
Colitis 46 53 1591 1598 I-clinical_variable
Clinical 54 62 1599 1607 I-clinical_variable
Score 63 68 1608 1613 I-clinical_variable
> 69 70 1614 1615 O
5 71 72 1616 1617 B-lower_bound

aspartate 0 9 1618 1627 B-clinical_variable
aminotransferase 10 26 1628 1644 I-clinical_variable
( 27 28 1645 1646 I-clinical_variable
AST 28 31 1646 1649 I-clinical_variable
) 31 32 1649 1650 I-clinical_variable
2 33 34 1651 1652 O
× 35 36 1653 1654 O
the 37 40 1655 1658 O
upper 41 46 1659 1664 O
limit 47 52 1665 1670 O
of 53 55 1671 1673 O
normal 56 62 1674 1680 O
( 63 64 1681 1682 O
ULN 64 67 1682 1685 O
) 67 68 1685 1686 O

budesonide 0 10 1687 1697 B-treatment
at 11 13 1698 1700 O
a 14 15 1701 1702 O
stable 16 22 1703 1709 O
dose 23 27 1710 1714 O
≤9 28 30 1715 1717 O
mg 31 33 1718 1720 I-upper_bound
/ 33 34 1720 1721 I-upper_bound
day 34 37 1721 1724 I-upper_bound
, 37 38 1724 1725 O
or 39 41 1726 1728 O
equivalent 42 52 1729 1739 O
steroid 53 60 1740 1747 B-treatment

leucopenia 0 10 1748 1758 B-clinical_variable
WBC 11 14 1759 1762 I-clinical_variable
count 15 20 1763 1768 I-clinical_variable
<3 21 23 1769 1771 O
× 24 25 1772 1773 I-upper_bound
109 26 29 1774 1777 I-upper_bound
/ 29 30 1777 1778 I-upper_bound
L 30 31 1778 1779 I-upper_bound

non 0 3 1780 1783 B-cancer
- 3 4 1783 1784 I-cancer
melanomatous 4 16 1784 1796 I-cancer
skin 17 21 1797 1801 I-cancer
cancer 22 28 1802 1808 I-cancer

planning 0 8 1809 1817 B-pregnancy
on 9 11 1818 1820 I-pregnancy
becoming 12 20 1821 1829 I-pregnancy
pregnant 21 29 1830 1838 I-pregnancy

prednisone 0 10 1839 1849 B-clinical_variable
at 11 13 1850 1852 O
a 14 15 1853 1854 O
stable 16 22 1855 1861 O
dose 23 27 1862 1866 O
≤30 28 31 1867 1870 O
mg 32 34 1871 1873 I-upper_bound
/ 34 35 1873 1874 I-upper_bound
day 35 38 1874 1877 I-upper_bound

